beta-alanine and adenosine diphosphate

beta-alanine has been researched along with adenosine diphosphate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cook, JJ; Ellis, JD; Hand, EL; Holahan, MA; Prueksaritanont, T; Sitko, GR; Stranieri, MT	1
Asai, F; Naganuma, H; Ogawa, T; Sugidachi, A	1

Other Studies

2 other study(ies) available for beta-alanine and adenosine diphosphate

Article	Year
Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogs. Biopharmaceutics & drug disposition, 1997, Volume: 18, Issue:8 Topics: Adenosine Diphosphate; Adjuvants, Anesthesia; Animals; Area Under Curve; beta-Alanine; Collagen; Cross-Over Studies; Dogs; Dose-Response Relationship, Drug; Half-Life; Injections, Intravenous; Male; Pentobarbital; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radioimmunoassay	1997
Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs. Thrombosis research, 2000, Mar-01, Volume: 97, Issue:5 Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspirin; beta-Alanine; Bleeding Time; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Hemostasis; Hypercholesterolemia; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Urea	2000

Article

Year

Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogs.

Biopharmaceutics & drug disposition, 1997, Volume: 18, Issue:8

Topics: Adenosine Diphosphate; Adjuvants, Anesthesia; Animals; Area Under Curve; beta-Alanine; Collagen; Cross-Over Studies; Dogs; Dose-Response Relationship, Drug; Half-Life; Injections, Intravenous; Male; Pentobarbital; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radioimmunoassay

1997

Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.

Thrombosis research, 2000, Mar-01, Volume: 97, Issue:5

Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspirin; beta-Alanine; Bleeding Time; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Hemostasis; Hypercholesterolemia; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Urea

2000